Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3697691 | 1.00 | ADRB3 (0.70) | ADRB3ADRB1 | |
| SCHEMBL9483243 | 1.00 | ADRB3 (0.70) | ADRB3ADRB1 | |
| SCHEMBL6133378 | 1.00 | ADRB3 (0.70) | ADRB3ADRB1 | |
| SCHEMBL9006797 | 1.00 | ADRB3 (0.70) | ADRB3ADRB1 | |
| SCHEMBL5188566 | 1.00 | ADRB3 (0.70) | ADRB3ADRB1 | |
| SCHEMBL9006647 | 1.00 | ADRB3 (0.70) | ADRB3ADRB1 | |
| Hydrochloric Acid SCHEMBL9317513 | 0.99 | ADRB3 (0.69) | ADRB3ADRB1 | |
| Hydrochloric Acid SCHEMBL10799438 | 0.99 | ADRB3 (0.69) | ADRB3ADRB1 | |
| Bromide SCHEMBL10800802 | 0.99 | ADRB3 (0.69) | ADRB3ADRB1 | |
| Hydrochloric Acid SCHEMBL9316504 | 0.99 | ADRB3 (0.69) | ADRB3ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0626367-B1 | (7S)-7-(1R)-2-(3-chlorophenyl)-2-hydroethylamino-5,6,7,8-tetrahydronaphtalen-2-yloxy acetic acid, their pharmaceutically acceptable salts with a beta-3-adrenergic agonist activity and pharmaceutical compositions containing them | SANOFI SA (FR) | 1997-04-09 | — | — | EP | disclosed |
| EP-0626367-A1 | (7S)-7-(1R)-2-(3-chlorophenyl)-2-hydroethylamino-5,6,7,8-tetrahydronaphtalen-2-yloxy acetic acid, their pharmaceutically acceptable salts with a beta-3-adrenergic agonist activity and pharmaceutical compositions containing them | SANOFI (FR) | 1994-11-30 | — | — | EP | disclosed |